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Steven D. Aird1*, Shikha Aggarwal1,2, Alejandro Villar-Briones1, Mandy Man-Ying Tin1, Kouki Terada3
and Alexander S. Mikheyev1,4*
Abstract
Background: While many studies have shown that extracellular proteins evolve rapidly, how selection acts on
them remains poorly understood. We used snake venoms to understand the interaction between ecology,
expression level, and evolutionary rate in secreted protein systems. Venomous snakes employ well-integrated
systems of proteins and organic constituents to immobilize prey. Venoms are generally optimized to subdue
preferred prey more effectively than non-prey, and many venom protein families manifest positive selection and
rapid gene family diversification. Although previous studies have illuminated how individual venom protein families
evolve, how selection acts on venoms as integrated systems, is unknown.
Results: Using next-generation transcriptome sequencing and mass spectrometry, we examined microevolution in
two pitvipers, allopatrically separated for at least 1.6 million years, and their hybrids. Transcriptomes of parental
species had generally similar compositions in regard to protein families, but for a given protein family, the
homologs present and concentrations thereof sometimes differed dramatically. For instance, a phospholipase A2
transcript comprising 73.4 % of the Protobothrops elegans transcriptome, was barely present in the P. flavoviridis
transcriptome (<0.05 %). Hybrids produced most proteins found in both parental venoms. Protein evolutionary rates
were positively correlated with transcriptomic and proteomic abundances, and the most abundant proteins
showed positive selection. This pattern holds with the addition of four other published crotaline transcriptomes,
from two more genera, and also for the recently published king cobra genome, suggesting that rapid evolution of
abundant proteins may be generally true for snake venoms. Looking more broadly at Protobothrops, we show that
rapid evolution of the most abundant components is due to positive selection, suggesting an interplay between
abundance and adaptation.
Conclusions: Given log-scale differences in toxin abundance, which are likely correlated with biosynthetic costs, we
hypothesize that as a result of natural selection, snakes optimize return on energetic investment by producing
more of venom proteins that increase their fitness. Natural selection then acts on the additive genetic variance of
these components, in proportion to their contributions to overall fitness. Adaptive evolution of venoms may occur
most rapidly through changes in expression levels that alter fitness contributions, and thus the strength of selection
acting on specific secretome components.
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Background
Selection acts differently on different proteins, depend-
ing on their function. Understanding mechanisms
underlying these differences has been a major thrust in
molecular evolutionary biology [1–6]. A dominant pat-
tern observed in studies of diverse model systems, ran-
ging from yeast to mammals, is that secreted proteins
evolve faster than intracellular proteins [7–11]. Rea-
sons for this phenomenon remain poorly understood.
Non-adaptive explanations posit that extracellular pro-
teins experience relaxed selection, and are more tolerant
of mutations for structural, ecological, or evolutionary rea-
sons [8, 9]. Alternatively, extracellular proteins may play a
larger role in evolutionary interactions with the environ-
ment and other organisms, which should make them more
likely targets of positive selection [10, 11], as predicted by
coevolutionary theory [12, 13].
In our view this uncertainty results from methodologies
used in previous studies, which focused on large-scale
analysis of evolutionary rate correlates. Although some
authors could identify major genome-wide patterns, given
the large number of genes involved, they could not deter-
mine proximal ecological factors that drive selection
acting on extracellular gene products. Here we use snake
venoms as a model system to illuminate the interplay be-
tween ecology and evolutionary rates of secreted proteins.
Consisting of analytically tractable numbers of compo-
nents with distinct pharmacological roles, snake venom
proteomes have well-defined ecological roles in the
immobilization of prey. Thus, comparing the compos-
ition of snake venoms between species as a function of
prey choice and venom protein expression level, can
provide general insights into how secreted proteins
evolve.
Snake venoms function as integrated systems. Roles of
individual constituents depend upon their concentra-
tions and their interactions with other venom compo-
nents [14]. Moreover, venom constituents also interact
with compounds in prey tissues, most often in highly
specific ways. Snake venom composition must respond
to ontogenetic and evolutionary changes in diet, and
presumably must also compensate to overcome predator
or prey resistance, should that develop [15–17]. As a
result, venoms from different species, and even those
from different populations of the same species, appear
optimally targeted to the chemistries of specific prey
species. Furthermore, the structures of snake venom
proteins evolve extremely rapidly (with a ratio of non-
synonymous to synonymous substitutions greater than
one), suggesting intense, positive, Darwinian selection.
Consisting of mixtures of specific, evolutionarily con-
served compounds with discrete pharmacologies, snake
venoms provide an unusual opportunity to quantitatively
study genomic consequences of ecological interactions,
particularly how natural selection acts on rapidly co-
evolving gene complexes.
Numerous and diverse studies attest to the strength of
selection operating on venom composition. Various stud-
ies document a close match between venom composition
and its effectiveness in subduing prey, suggestive of adap-
tation by the snakes. For example, Mackessy [18] showed
that northern and southern Pacific rattlesnakes (Crotalus
viridis oreganus and C. v. helleri) exhibit a pronounced
shift in venom chemistry when young adults switch from
lizard to rodent prey. The venom becomes less toxic, but
much more proteolytic, presumably to enhance digestion
of more voluminous prey with much smaller surface-to-
volume ratios [19], although McCue [20] has disputed this
conclusion. Daltry et al. [21] opined that venom variation
in the Malayan pitviper (Calloselasma rhodostoma) is
closely associated with diet. Chijiwa and colleagues [22]
documented stark differences in venom phospholipases
A2 (PLA2s) in populations of habus (Protobothrops flavo-
viridis) on different islands in the Ryukyu Archipelago.
They inferred that these compositional differences reflect
different selective pressures related to preferred prey. Ex-
perimental studies have shown that coral snake venoms
are most toxic to preferred prey organisms [23]. Gibbs
and Mackessy [24] found that toxicity of four pygmy
rattlesnake (Sistrurus) venoms was correlated with the
proportion of mice and lizards in the diet, with each taxon
being most toxic to its preferred prey species. Conversely,
the sea snake, Aipysurus eydouxii, feeds exclusively on fish
eggs, obviating the necessity of venom. As a result, selec-
tion on its venom PLA2s has relaxed, leading to a range of
dysfunctional mutations [25, 26].
In addition, many studies that focused on individual
toxins or toxin classes have discovered evidence of ac-
celerated protein sequence evolution, consistent with
positive selection. It is well documented that contrary
to normal tissue isozymes, venom protein exons diver-
sify much more rapidly than introns [27–31]. In most
venomous snakes, toxin gene duplication followed by
neofunctionalization, has resulted in diverse pharmacol-
ogies [32, 33]. As an example, PLA2s manifest presynaptic
neurotoxicity, myotoxicity, cardiotoxicity, anticoagulation,
and cause vascular perforation (hemorrhage), hemolysis,
and pain [34–36]. Although not as well studied as PLA2s,
other snake toxin classes including cysteine-rich secretory
proteins (CRISPs), disintegrins, C-type lectins, serine pro-
teases, metalloproteases, and three-finger toxins all show
evidence of rapid gene diversification, or of positive Dar-
winian selection [33, 37–43]. Moreover, the most rapidly
evolving residues are those that appear on toxin surfaces,
controlling their interactions with molecular targets in
prey organisms [32, 44].
Some have suggested that accelerated evolution is pre-
dominantly a product of intrinsic mechanisms that enhance
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genetic diversity, independent of selective pressures. Kini
and Chan [44] reasoned that accelerated evolution results
from relaxed rather than directional selection. Mebs [45]
argued that there is no evidence that strong selective forces
drive the development of more potent toxins to overcome
prey resistance, or to exploit new biochemical pathways for
more effective intoxication of prey. More recently Kini
and Chinnasamy [46] proposed that triplet nucleotide
sequences determine the spontaneous mutation rate, an
idea that requires further consideration.
In addition, phylogeny clearly plays a role in venom
composition. More closely related species generally have
more similar venoms than more distantly related species
(e.g. the four mamba species have venoms that are quali-
tatively similar, but distinctly different from those of all
other elapids). However, geography, and reduced gene
flow may also influence venom chemistry. Angulo et al.
[47] found pronounced differences in venom compos-
ition (only ~15 % similarity) between Atropoides nummi-
fer and Atropoides picadoi. Since adults of both species
are predominantly rodent predators, the differences
appear to have a phylogenetic, rather than an ecological
or geographic basis. However, the earlier work of
Jiménez-Porras makes it clear that geographic separation
of conspecific populations also affects venom compos-
ition in A. nummifer [48]. Angulo et al. did not indicate
the geographic origins of their specimens, except to say
that all were collected in Costa Rica.
Although toxin components interact to immobilize
prey [14], historically, most studies of snake venom
constituents have focused on specific toxin classes,
examining long-term evolutionary trends in a variety of
snake taxa. Consequently, although macroevolutionary
patterns of individual venom proteins are somewhat
understood, their regulation and microevolution remain
almost entirely unknown [49]. However, if individual
toxins (gene products) fluctuate in abundance and im-
portance over short evolutionary time scales [50], evolu-
tionary analysis of individual venom constituents may be
misleading, as individual genes may experience different
selective pressures from lineage to lineage. Furthermore,
rates of venom protein evolution may depend on the
relative abundance of various venom protein classes, and
on their relative importance in immobilizing the prey.
Here we examine the interplay between component
abundance and evolutionary rate, using two closely
related pitviper species, the habu (Protobothrops flavovir-
idis) and the Sakishima habu (Protobothrops elegans).
The former is native to Okinawa and nearby islands, and
the latter to the Yaeyama Islands, located 400 km to the
southwest in the Ryukyu Archipelago. The Sakishima
habu is most closely related to the Taiwan habu (P.
mucrosquamatus) [51], which is not surprising since it
occupies the Ryukyu Islands closest to Taiwan. In 1976,
however, human activities released approximately 100
Sakishima habus in the vicinity of Itoman, Okinawa
[52–54]. The geological isolation of the Yaeyamas and
Okinawa, is estimated at about 1.6 million years, which
matches patterns of divergence of several island endemics
[51, 55–57], though molecular estimates place divergence
between these species at about 10 million years [58].
Between 1990 and 2000, more than 500 Sakishima
habus were captured and brought to the Prefectural
Institute of Health and Environment [53]. During this
same period, five specimens of intermediate morphology
were collected, suggesting possible hybridization. Recent
collection of two more intermediate specimens prompted
us to investigate whether these specimens are actual hy-
brids. Using a combination of transcriptomic and quanti-
tative proteomic techniques [42], we identified venom
components and determined their abundances in three
specimens each of both parental species, and in the two
putative hybrids, all collected in the same local area
(Fig. 1). Because the putative hybrids are rare, and could
not be sacrificed for venom gland extraction, we used only
proteomic analysis of their venoms. We confirmed that
they are genuine hybrids; however, serendipitously, these
data also revealed some surprising patterns in the tempo
and pattern of secreted protein evolution. Thus, an os-
tensibly simple question of possible pitviper hybridization
unexpectedly illuminated fundamental evolutionary prin-
ciples, which we could then verify in other species. Here
then, are both intertwined stories.
Results and discussion
We used a combination of transcriptomic and proteomic
techniques to characterize the venoms of two closely re-
lated habus. By combining both approaches, we benefitted
from the dynamic range and accuracy of transcriptomics,
while proteomic data distinguished between proteins se-
creted into the venom, and non-venom components,
allowing us to contrast evolutionary patterns in the two
classes of genes. In addition, proteomics permitted us to
quantify venom composition in rare and valuable hybrid
specimens that could not be sacrificed for gland extrac-
tion. Unexpectedly, however, these hybrids provided in-
sights into venom level regulation and evolution, showing
heritability and additive regulation of venom component
expression levels.
We also found a positive correlation between abundance
of venom gene transcripts, and their evolutionary rates.
This result is not obvious, given the non-stoichiometric
action of enzymatic snake venom components, but it sug-
gests that venomous snakes invest more in the production
of proteins that are particularly important to them. Conse-
quently, these proteins experience high rates of evolution,
often with ω > 1, and show evidence of positive selection
(Fig. 6; Additional file 1: Table S3). We propose that
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regulation of venom constituent levels may be a major
short-term mechanism by which snakes adapt to new prey
types, and may be a driver of protein molecular evolution.
The two Protobothops venoms were qualitatively simi-
lar at the level of protein families, and had many one-to-
one gene homologs (Fig 3). Both venoms were heavily
dominated by phospholipases A2, serine proteases,
metalloproteases, and BPP-CNP, in that order (Table 1).
Protobothrops flavoviridis venom possesses Factor IX/X
inactivators that are absent in P. elegans venom. LAO
transcripts were 6× more abundant in habu venom and
VEGF transcripts were 3× as numerous (Table 1).
Toxins having the primary function of hypotension or
anti-coagulation, account for at least 21 % more of the
P. flavoviridis transcriptome than the P. elegans tran-
scriptome (Table 1). Presently, it is not possible to know
whether any of the phospholipases A2 in either venom
are anticoagulant; however, Zhao et al. [59] present
strong evidence that catalytic activity is required for
anticoagulant activity. This implies that the major P.
elegans myotoxic PLA2 is not anticoagulant, while the
two major PLA2s of P. flavoviridis venom may be. Taken
together, it appears that the envenomation strategy of P.
flavoviridis is focused much more heavily on provoking
hypotension and distributing venom proteins throughout
the prey, strategies that makes sense for mammalian
prey, with much smaller surface-to-volume ratios than
lizards, on which even adult P. elegans feed.
Herein we address the composition of parental and
hybrid venoms, confirmation of the hybrid status of the
putative hybrids, and how natural selection acts on
venoms as integrated systems.
Composition of parental and hybrid venoms
Phospholipases A2
Both Protobothrops venom gland transcriptomes were
dominated by phospholipases A2 (PLA2s). In the Protobo-
throps elegans transcriptome, two PLA2s comprised 76.9 %
of all transcripts whereas in P. flavoviridis four isozymes
represented 55.5 % (Table 1; Additional file 2: Table S1 and
Additional file 3: Table S2). The PLA2 content in the P.
elegans transcriptome is very high, but reasonable in light
of pit viper venom chemistry. For example, in some neo-
tropical rattlesnake (Crotalus durissus) venoms, crotoxin, a
heterodimeric, PLA2 neurotoxin can comprise as much as
88 % of total venom protein [60–62].
Based on homology to other PLA2s of known pharmacol-
ogy, P. elegans transcript comp43_c0_seq1 that constituted
73.4 % of all transcripts, encodes a noncatalytic, myotoxic
PLA2 myotoxin that shows considerable homology to other
Asian crotaline myotoxins (Fig. 2a; Additional file 4: Figure
S1A; Additional file 5: Figure S3; Additional file 2: Table
A  Protobothrops flavoviridis B  Protobothrops elegans
C  Protobothrops flavoviridis x Protobothrops elegans hybrid
Fig. 1 Photographs of the two parental species and a hybrid between them. a Protobothrops flavoviridis. b P. flavoviridis x P. elegans hybrid.
c Protobothrops elegans. Protobothrops flavoviridis, as the name implies, has a yellow-green ground color, whereas P. elegans tends to be more
orange to red, and head markings are quite different. Protobothrops flavoviridis is also much larger, reaching a maximum length of 2.5 m. The
intermediate markings and color of the hybrids provided the impetus for an investigation of their venom chemistry
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S1). In contrast, while P. flavoviridis also has a transcript
(Pf_comp552_c0_seq1) for a homologous, non-catalytic,
myotoxic PLA2, this transcript represents <0.05 % of the
latter transcriptome. Both the P. elegans and P. flavoviridis
myotoxins have an arginine residue (position 48) where
catalytic PLA2s have aspartic acid in order to bind the
Ca2+ ion required for catalysis. Many New World cro-
talines have lysine in this position. All three P. elegans spec-
imens and the two hybrids express Pe_comp43_c0_seq1
heavily, but no snakes in this study produced the P. fla-
voviridis homolog, Pf comp552_c0_seq1 (Fig 3; Fig. 2;
Additional file 6: Figure S5).
All other PLA2s in both venoms are presumably
catalytic. The dominant PLA2s in P. flavoviridis venom
(Pf comp41_c0_seq1 and comp40_c0_seq1) are both
basic, as is P. elegans comp47_c0_seq1, which is hom-
ologous to Pf comp41_c0_seq1. Their pharmacologies
are unknown. All three P. elegans venoms contained
Pe_comp47_c0_seq1, but none of the P. flavoviridis
PLA2s. Likewise, all three P. flavoviridis venoms
contained the three Pf PLA2s, but not Pe comp47_c0_
seq1. The hybrids, however, produced all five PLA2s
from both parental species (Fig 3; Fig. 2; Additional
file 6: Figure S5).
Protobothrops elegans venom apparently has no neuro-
toxic PLA2s, but P. flavoviridis comp48_c0_seq1, which
encodes a weak presynaptic neurotoxin similar to trimucro-
toxin [63], comprised 6.3 % of the P. flavoviridis transcrip-
tome. Although some neurotoxic PLA2s are also myotoxic
[64, 65], myotoxicity appears to be much more important
for P. elegans than for P. flavoviridis. Nonetheless, it is
difficult to offer an ecological explanation for this differ-
ence. In general, myotoxicity seems to be most often associ-
ated with mammal predation by large terrestrial crotalines
[66–68], but it has also been reported in small arboreal
species [69]. Without appropriate pharmacological studies
in native prey species as well as laboratory animals, it is
impossible to know whether such differences are adaptive
or ecologically irrelevant. It may be that some subsets of
myotoxic PLA2s are specifically adapted to reptilian rather
than mammalian skeletal muscle, but if so, the structural
determinants are currently unknown.
Relative to PLA2s, one other matter deserves mention.
The P. elegans cDNA library contains a peculiar transcript,
Pe_comp103_c0_seq1, that represented 0.2 % of the tran-
scriptome (Additional file 2: Table S1). Using the Frame 3
reverse translation of comp103_c0_seq1, BLASTP and
TBLASTX searches both suggested that the best match is a
PLA2 gene cluster from P. flavoviridis (in Frame 1) [70].
However, both sequences are liberally punctuated with stop
codons, and the longest, unbroken, translated segment of
the P. elegans transcript, using Frame 1, encodes only 45
amino acids, or about 37 % of a typical Type II PLA2.
BLASTP and pfam searches for the 45-residue protein
yielded no results. However, mass spectrometry of the eight
venoms detected three peptides (a total of 46 times) that
cover 55.8 % of the putative protein translated in Frame 1
(Fig 3). Further analysis of these peptides was done using
de-novo sequencing algorithms and manual annotation, in
order to confirm their identity (Additional file 7: Figure S2).
This protein was not only detected in all three speci-
mens of P. elegans; it was also detected in both hybrid
venoms (Fig 3). Clearly, the snakes are producing this,
but it does not appear to be a PLA2 derivative, the
TBLASTX searches notwithstanding. Its function, as-
suming that it has one, is unknown.
Serine proteases
In both transcriptomes, serine proteases (SPs) are the
second most abundant protein family (Table 1). Six SPs
comprise 10.4 % of all P. elegans transcripts, whereas
eight represent 11.8 % of all P. flavoviridis transcripts.
Table 1 The Protobothrops elegans and P. flavoviridis
transcriptomes are overwhelmingly dominated by PLA2s;
however, the major PLA2s in each are pharmacologically very
different. P. flavoviridis venom appears to be much more
anti-coagulant, with coagulation Factor IX/X-binding proteins,
and higher percentages of serine proteases, LAO, C-type lectins,
5′-nucleotidase, and phosphodiesterase [14]




Phospholipase A2 77.1 % 55.5 %
Serine protease 10.4 % 11.8 %
Metalloprotease P-II 4.8 % 11.3 %
Metalloprotease P-III 3.2 % 6.0 %
BPP-CNP 1.4 % 2.6 %
Factor IX/X Activator A 2.4 %
Factor IX/X Activator B 1.2 %
LAO 0.5 % 3.1 %
VEGF 0.5 % 1.7 %
Phospholipase B 0.2 % 0.3 %
C-Type Lectin B 0.2 % 0.3 %
CRISP 0.1 % 2.0 %
5′-Nucleotidase 0.1 % 0.3 %
Nerve Growth Factor 0.1 % 0.1 %
Phosphodiesterase 0.1 % 0.2 %
Metalloprotease P-I 0.1 %




QC 0.0 % 0.1 %
Hyaluronidase 0.0 %
DPP-IV 0.0 % 0.0 %
APA 0.0 % 0.0 %
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Based on homology, P. elegans SP 1 (5.5 % of all tran-
scripts) (Additional file 2: Table S1), is a thrombin-like
enzyme (TLE) and a possible kallikrein. Protobothrops
elegans SPs 2, 3, and 6 are probable TLEs, while based
on BLASTP searches, SPs 4 and 5 are probable plas-
minogen activators. Protobothrops flavoviridis SPs 1 and
4 are probably TLEs, based on sequence homology to
DAV-PA from Deinagkistrodon acutus venom (Additional
file 3: Table S2). Protobothrops flavoviridis SP2, a complete
transcript, is an isoform of a serine protease variously
known as habutobin or flavoxobin. It is a strongly anti-
coagulant thrombin-like enzyme that releases only fibrino-
peptide A [71, 72], inhibits collagen-induced platelet
aggregation [73], and releases urokinase-tissue plasminogen
activator from bovine arterial endothelial cells [74]. In
addition, it functions as a C3-convertase that activates the
complement cascade [75]. SP5 most closely resembles
KN5 from Viridovipera stejnegeri venom (Tsai and Wang,
direct submission: http://www.ncbi.nlm.nih.gov/protein/
82239734), for which no pharmacological data are avail-
able. SP7 is a probable plasminogen activator, based on
similarity to another homolog from V. stejnegeri venom
[76]. The majority of the SPs in both venoms appear to
function in multiple ways as anticoagulants. As with
PLA2s, the hybrids produce SPs from both parental spe-
cies, but all peptides could be attributed to specific paren-
tal transcripts; there were no peptides of ambiguous
(potentially common) origin.
At first glance, it might appear contradictory for snakes
to employ both procoagulant and anticoagulant enzymes,
but in reality, this is a well-coordinated strategy to render
the prey’s blood wholly incoagulable with astonishing
speed. Venom thrombin-like enzymes (TLEs) consume
fibrinogen, yielding small fibrin clots, and hypotensive
fibrinopeptides [77, 78]. However, the commencement
of inappropriate clotting triggers the prey’s anti-clotting
cascade, which rapidly destroys the fibrin clots [79].
Protobothrops flavoviridis venom contains a Factor IX/
X inactivator (3.6 % of the transcriptome) that is lack-
ing in P. elegans venom, and kallikrein-like enzymes,
which P. elegans does have (Additional file 2: Table S1,
Additional file 3: Table S2). But kallikrein converts
plasminogen to plasmin, which in turn, digests fibrin.
Various venom serine proteases have both thrombin-
like and kallikrein activities [80–85]; thus fibrinogen-
clotting and plasminogen activation reside in the same
protein. Regardless, many crotaline venoms also contain
serine and metalloproteases that degrade fibrin directly
[86, 87].
Many snake venom TLEs clot fibrinogen less effect-
ively than thrombin [88] and TLEs are commonly more
effective against fibrinogens of some mammal species
than others [89], but the existence of so many weakly
clotting TLEs, the capacity of various crotaline TLEs to
degrade prothrombin [90], and the existence of directly
fibrinolytic venom enzymes, confirm that the objective is
not to clot blood, but to clear the bloodstream of fibrinogen
[91]. Even in human envenomations by small crotalines,
blood can be rendered incoagulable within minutes [92].
Defibrinogenation would occur in small mammalian prey
far more rapidly. Incoagulable blood presumably facilitates
the distribution of venom and endogenous prey tissue
A
B
Fig. 2 Protobothrops flavoviridis x P. elegans hybrids express phospholipases A2 from both parental venoms. a Aligned PLA2 transcripts from P.
flavoviridis and P. elegans transcriptomes. The solid heavy vertical line separates the signal peptides from the expressed PLA2s. A noncatalytic,
myotoxic PLA2 transcript (comp43_c0_seq1) from P. elegans specimen #3 accounted for 73.4 % of all P. elegans transcripts (Additional file 2: Table
S1). This protein was heavily expressed in all three specimens and in both hybrids (Fig 3). A homologous transcript was found in the transcriptome
of P. flavoviridis specimen #3, but it constituted less than 0.05 % of all P. flavoviridis transcripts (Additional file 3: Table S2). No peptides from this myotoxic
PLA2 transcript were detected in venoms of any P. flavoviridis specimens, or of the hybrids (Fig 3). P. elegans transcript comp47_c0_seq1 is homologous to
P. flavoviridis transcript comp41_c0_seq1 (Fig 3). P. elegans specimens expressed the PLA2 corresponding to the former transcript, while P. flavoviridis
specimens expressed the latter. Hybrids expressed both (Fig 3; Additional file 8: Figure S5). The P. flavoviridis transcriptome also contained two additional
PLA2 trancripts, comp40_c0_seq1 and comp48_c0_seq1 (Additional file 3: Table S2). These had no homologs in the P. elegans transcriptome, but hybrids
produced both of these, as did all three P. flavoviridis specimens (Fig 3; Additional file 8: Figure S5). b Peptide coverage of venom PLA2 transcripts is similar
between hybrids and non-hybrid specimens. Peptides from P. elegans venoms are indicated by green bars above the sequences, while those from P. flavo-
viridis venoms are in blue and those of hybrids are in gray. For any given transcript, peptides were sequenced from essentially the same portions of the
PLA2 in both hybrid and non-hybrid venoms
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Fig. 3 (See legend on next page.)
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hydrolases, promoting prey digestion. In addition to fibrin
cleavage, plasmin also inactivates many endogenous
clotting factors, thereby acting as an anticoagulant
[93]; however, this also suggests that the strategy may
be to prevent endogenous coagulation factors from
producing properly clotted fibrin. For a more detailed
look at the role of serine proteases in envenomation,
see the Additional file 9.
Metalloproteases
In both transcriptomes, P-II metalloproteases are the third
most abundant protein family (P. elegans: 4.8 % and P.
flavoviridis: 11.3 %), followed by P-III metalloproteases (P.
elegans: 3.2 % and P. flavoviridis: 6.0 %) (Table 1).
Protobothrops elegans venom contains as many as six P-II
MPs, one apparent P-I MP, and as many as nine P-III
MPs. However, caution must be exercised in predicting
the number of members of these highly diversified fam-
ilies. From previous experience, it is clear that partial tran-
scripts of large proteins tend to overestimate numbers of
homologs and paralogs in these families [42]. Our earlier
study suggested that there could be as many as 12 P-II
MPs and as many as 9 P-III MPs in P. flavoviridis venom.
The present study found evidence for no more than 4 P-II
MPs, but suggested as many as 11 P-III MPs (Additional
file 3: Table S2). The problem seems to be that the Trinity
assembler is unable to deal effectively highly diversified
families of large proteins, such as MPs and SPs. Reassembly
of both transcriptomes using the new assembler, VTBuilder,
suggested assembling two pairs of these (Pf_comp65_co_
seq1 with Pf_comp75_c0_seq1; Pf_comp69_c0_seq1
with Pf_comp72_c0_seq1), resulting in an estimated 7
P-III MPs. Nonetheless, overall, the two studies present
a unified view of the relative importance of the various
toxin families.
The putative P-I metalloprotease transcript identified
in the P. elegans transcriptome had no apparent homo-
log in P. flavoviridis. Oddly, while peptides from this
protein were not identified in any of the P. elegans
venom samples, Hybrid #2 did express it. P-II metallo-
proteases were expressed in the hybrids at the slightly
lower levels than those seen in either of the parental
venoms. Four of five P. elegans enzymes were identified
in the hybrids and three out of four from P. flavoviridis.
In the two parental species, P-II metalloproteases were
expressed somewhat more highly than P-III enzymes.
MPs were expressed at about 12–15 % in both hybrids
(Fig 3; Additional file 6: Figure S5).
It is difficult to predict metalloprotease pharmacology
based upon subclass identity alone, owing to a dearth of
comparative structure-function studies. The structural
complexity of P-III enzymes in particular, gives rise to a
great variety of pharmacologies, including hemorrhage,
inflammation, apoptosis, fibrinogen and fibrin degrad-
ation, prothrombin activation, and platelet aggregation
inhibition [94]. The extremely hemorrhagic nature of P.
flavoviridis venom is well known [95–98], and that
characteristic reflects the well-documented presence of
hemorrhagic MPs [99–102]. P-III MPs 2, 4, 7, 9, and 11
are clearly isomers of HR1, a hemorrhagic P-III MP
(Additional file 3: Table S2) [103–106]. MP P-IIIs 1, 3, 5, 6,
8, and 10 appear homologous to flavorase (HV1), character-
ized as an apoptosis-inducing protein (Additional file 3:
Table S2) [107]; however, apoptosis is too slow a process
to be relevant to envenomation; its more important
contribution to envenomation is probably to degrade fi-
brinogen [108].
(See figure on previous page.)
Fig. 3 Proteomic data demonstrate that the two hybrids are genuine. Peptides from all specimens were matched to transcripts from both
parental species (*specimens Pe 3 and Pf 3). Homologous proteins are aligned on the same row. Proteins without homologs in the other
transcriptome occupy their own rows. Percentages at the bottom of the hybrid columns indicate the percentage of all peptides in the hybrid
proteome corresponding to transcripts in each of the parental species. For the hybrids, numbers of unique peptides corresponding to each of
the parental transcripts are provided in color-coded columns (green = P. elegans; blue = P. flavoviridis). If a peptide could have come from one
or more transcripts in both parental species, it was classified as “common” (pink), meaning that it was potentially common to both, or that its
origin was indeterminate. Total percentages of peptides from each protein family are given in bold. Hybrid percentages for each pair of venom
protein homologs are shown in gray columns. Peptides that corresponded to missing portions of incomplete transcripts could not be identified.
Despite huge advances in mass spectrometric technology, shotgun sequencing is still less quantitative than transcriptomic approaches, so
proteomic totals differ quantitatively from those presented for transcriptomes (Additional file 2: Table S1 and Additional file 3: Table S2) In the
Phospholipase A2 section, 613 peptides from a noncatalytic, myotoxic PLA2 (transcript Pe_comp43) were detected in the venom of Hybrid 1 and
338 peptides were isolated in venom of Hybrid 2. It was also found in venoms of all three P. elegans specimens. Neither the hybrid venoms nor
the three P. flavoviridis venoms contained peptides from the homologous PLA2 (transcript Pf_comp552). Likewise, peptides from two P.
flavoviridis PLA2 transcripts (Pf_comp40 and 48), with no homologs in the P. elegans transcriptome, were found in the venoms of all three P.
flavoviridis and those of both hybrids, but not in the three P. elegans venoms. In contrast, P. elegans transcript Pe_comp47 and P. flavoviridis
transcript Pf_comp41 encode a basic, catalytic PLA2, homologous to PL-Y. Both hybrids had peptides corresponding to each of these transcripts
while specimens of the two species had only their own Hybrid 1 had 254 common PLA2 peptides (pink) and Hybrid 2 had 283, comprising 4.8
and 5.6 % of the two hybrid proteomes, respectively. These peptides could have originated with transcripts in both parental venom proteomes
and could not be assigned unambiguously to any single transcript. In Hybrid 1 venom, 24.4 % of all peptides detected were PLA2 peptides, while
this class accounted for 22.8 % of the peptides identified in Hybrid 2 venom. Most other protein families tell a similar story. Venom composition
of the putative hybrid venoms confirm that the specimens are legitimate hybrids
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Despite the presence of an apparent P-I MP in the P.
elegans transcriptome, we are unable to say whether an
independent P-I MP exists in this venom, or whether
this represents an incomplete P-II or P-III transcript.
The putative P-I transcript was itself incomplete and repre-
sented only 0.1 % of the transcriptome. Moreover, no pep-
tides from this transcript were found in any of the three P.
elegans venoms, although they were found in the venom of
hybrid #2. Graminelysin I, from the venom of Trimeresurus
gramineus, a P-I MP, has been shown to be processed
post-translationally from a P-III precursor [109], but
that situation is probably not analogous to this one.
Bradykinin-potentiating peptides and C-type natriuretic
peptide
The gene that encodes multiple bradykinin-potentiating
peptides and a single C-type natriuretic peptide (BPP-CNP)
was found in both transcriptomes (P. elegans: 1.4 %
and P. flavoviridis: 2.6 %) (Table 1). All of these gene
products are hypotensive, at least in mammals, and
cause prey to go into circulatory shock, limiting prey
flight [14]. These peptides were more highly expressed
in P. flavoviridis venoms and peptides from hybrid
venoms corresponded only to the P. flavoviridis transcript
(Fig 3; Additional file 6: Figure S5).
Other venom constituents
C-type lectins that act upon blood platelets were found in
the transcriptomes and proteomes of both species and
hybrid venoms showed peptides from both parental
venoms (Fig 3; Additional file 6: Figure S5). Protobothrops
flavoviridis produces an anticoagulant C-type lectin that
binds and inactivates coagulation Factors IX/IXa and
X/Xa [110, 111], but P. elegans does not. Both hybrids
manifested this protein, but at levels substantially
lower than seen in P. flavoviridis (Fig 3; Additional file
6: Figure S5).
L-amino acid oxidase represented 3.1 % of the P.
flavoviridis transcriptome, but only 0.5 % in P. elegans
(Tables 1, Additional file 2: Table S1 and Additional file
3: Table S2). However, LAO peptides accounted for
14.9 % of the P. elegans venom proteome and 13.4 % in
P. flavoviridis (Fig 3). Vascular endothelial growth fac-
tor, was an even more minor element of the two tran-
scriptomes (1.7 % of P. flavoviridis, but only 0.5 % of P.
elegans). All other components represented less than
1 % of one or both transcriptomes (Tables 1,
Additional file 2: Table S1 and Additional file 3: Table
S2). These included phospholipase B, cysteine-rich
secretory proteins, 5′-nucleotidase, nerve growth factor,
phosphodiesterase, galactose-binding lectin, glutaminyl
cyclase, hyaluronidase, dipeptidyl peptidase IV, and
aminopeptidase A. Pharmacologies of these proteins
relative to their roles in envenomation have been reviewed
in Aird [14] and Aird et al. [42].
“Common” peptides in the hybrid proteomes
For most protein families, it was possible to detect in
the hybrid venoms, a large number of unique peptides
that could be assigned to specific transcripts from each
of the parental species (Fig 3; Additional file 6: Figure
S5). However, for some families there were a large num-
ber of peptides that could be matched to one or more
transcripts in both parental venoms. That is, they were
potentially common to both. Not surprisingly, the per-
centage of common peptides in the hybrid proteomes
was greatest in the least diversified protein families.
These families generally have only one transcript per
species. Examples include APA (69.4 % common), LAO
(55.6 %), PDE (67.2 %), and CRISP (51.8 %) (Fig 3). Two
stark exceptions were 5′-nucleotidase and PLB (0 %).
Highly diversified protein families showed much lower
percentages of common peptides, the extreme case be-
ing serine proteases, for which no common peptides
were found.
Quantitative proteomics of the hybrids
Proteomic data can be quantified by standardizing abso-
lute peptide abundance by the predicted protein length
[42]. This approach produced significant correlations be-
tween protein and transcriptomic abundance estimates,
with close agreement between protein sample replicates
from different individuals (Fig. 4). However, reference
transcripts were only available for the parent species,
and not for the putative hybrids. In order to make com-
parisons of protein abundance, a common reference was
needed. We identified peptides using each transcriptome
as a reference, in order to determine which performed bet-
ter. The P. flavoviridis reference produced the most signifi-
cant correlation between transcriptomic and proteomic
data for both species (Spearman correlation with P. elegans:
r = 0.29, p = 0.011, P. flavoviridis r = 0.50, p = 5.3 × 10−9), so
it was used to call peptides for the hybrids (Fig. 4).
Non-metric, multidimensional scaling analysis of the
putative hybrid proteomes showed that they were largely
intermediate between those of the parental species
(Fig. 5a). The expression level of homologous venom
components was similarly intermediate (Fig. 5b).
Confirmation of the putative hybrids
The two putative hybrids expressed all venom proteins
from both parental species, except for those correspond-
ing to the most minor transcripts (Fig 3; Additional file
6: Figure S5), and had distinct venom profiles (Fig. 5).
Venom proteins produced by only one of the parental
species also appeared in hybrid venoms (e.g., P. elegans
PLA2 Pe_comp43_c0_seq1 and P. flavoviridis Factor IX/
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X inactivators, Pf_comp55_c0_seq1 and Pf_comp76_c0_
seq1) (Fig 3; Additional file 5: Figure S3). They also had
roughly intermediate levels of protein expression for
most venom proteins, compared to the parental species
(Fig 3, Fig. 5; Additional file 8: Figure S4; Additional file
6: Figure S5). The strong correlation between protein
levels in the two parental species and in the hybrids
indicates that venom levels are genetically controlled
(Fig. 5). Hybrid venom protein levels are largely inter-
mediate between those of the parental species, suggesting
that each component may be largely additively regulated,
though there is also evidence that hybrids show higher
levels of proteins, relative to the two parental species,
perhaps a manifestation of “hybrid vigor”. Additive ef-
fects, as opposed to dominance and epistatic effects,
are particularly good targets for natural selection [112],
though, more generally, genetic control of venom con-
stituent levels makes them a potential target for natural
selection. Consequently, rapid population-level changes
in venom chemistry are expected in the face of sufficient
selective pressure. This mode of regulation is consistent
with the rapid evolution of snake venoms seen in Protobo-
throps and other taxa.
Given their morphological intermediacy, and the addi-
tive compositions of their venoms, it is apparent that the
putative hybrids are, in fact, bona fide hybrids. We know
of no other way to explain the “hybrid” nature of these
venoms except for hybridization between the native P.
flavoviridis and the invasive P. elegans.
While the morphologically intermediate animals (Fig. 1)
are legitimate hybrids, without tissue samples, it is impos-
sible to determine which parent pertained to which spe-
cies, and we also cannot be certain whether the hybrids
are F1 or F2 hybrids. Given the substantial intermediacy
of hybrid venom composition relative to the two parental
species, it is virtually certain that they do not represent
back-crosses with either parental species, which would be
expected to skew venom composition toward that parental
rs =  0.51


























Fig. 4 Transcriptomic and proteomic data present generally concordant pictures. When mapped against their own references, the proteomic and
transcriptomic measures of abundance were correlated (Spearman rank p = 1.5 × 10−9, 5.3 × 10−9, for P. elegans and P. flavoviridis, respectively).
Individual proteomic samples are represented by different shapes, with the sample used for the reference transcriptome shown as an open circle.
Since only one transcriptome was sequenced for each species, biological replicates share the same X-coordinate. The methodology employed
herein was that reported in [42]
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species. Nonetheless, it is clear that P. elegans and P. flavo-
viridis are not reproductively isolated by pre-mating isolat-
ing mechanisms. Hybridization with invasive species can
threaten conservation of P. flavoviridis, and future studies
should address its extent and impact.
How natural selection operates on venoms
Evolutionary rate analysis
Venom gland transcripts for which venom peptides were
sequenced by mass spectrometry, had much higher rates
of non-synonymous to synonymous (dN/dS) substitutions
relative to tissue components of the venom gland tran-
scriptomes (Kruskal-Wallis p-value = 1.8 × 10−10) (Fig. 5a).
Among the proteins detected in either P. elegans or P.
flavoviridis venom by mass spectrometry, there was a
positive correlation between the average abundance of
a toxin in the transcriptome, and its evolutionary rate
(r = 0.53, d.f. = 24, p = 0.0055; Fig. 5b). Including only
proteins detected in both venoms, the correlation
remained, at lower significance, due to the decreased
sample size (r = 0.48, d.f. = 17, p = 0.037). Protein abun-
dance levels were likewise correlated with evolutionary
rate (r = 0.62, d.f. = 17, p = 0.0041). By contrast, the
transcriptional abundance of non-venom (tissue protein)
transcripts was negatively correlated with evolutionary
rate (rs = -0.087, n = 1012, p = 0.0057). There was evidence
of positive, significant selection acting on most venom
proteins with dn/ds >1. PLA2s, metalloproteases and C-
type lectins all showed evidence of positive selection in
Protobothrops as a whole (p < 0.05). PARRIS failed to
detect positive selection acting on serine proteases (p =
0.34, despite inferring dn/ds = 1.27; Table S3), but MEME
found significant evidence of episodic diversifying selec-
tion at four sites, a result consistent with the absence of
common peptides (Fig 3).
Control of expression levels
Differences in abundance of homologous proteins between
P. flavoviridis and P. elegans are dramatic. It is possible that
the expression level of each venom component is simply a
function of its promoter strength. In such a case, we would
predict that individual toxin levels should be weakly corre-
lated with levels of other transcripts, and that promoter re-
gions should show classical signs of positive selection, such
as reduced haplotypic diversity, and strong sequence diver-
gence between species. Both of these predictions can be
tested by conducting a gene co-expression level analysis
study, and an investigation of genetic diversity upstream of
venom toxin genes, respectively.
Energetics and selection
Although enzymatic venom constituents do not act stoi-
chiometrically as non-catalytic toxins do, nonetheless,
greater abundance necessarily signifies a greater role for
the constituent in question in prey immobilization and/
or digestion, regardless of the presence or absence of
catalytic activity. Snake venoms are the most concen-
trated glandular secretions in the animal kingdom, with
solutes, 90 % of which are proteins, comprising 25–35 %































Fig. 5 Hybrid snakes have protein expression profiles distinct from those of the parental species. a The non-metric multidimensional scaling
(NMDS) analysis of protein composition and abundance showed that protein levels in the hybrid venom proteomes showed intermediate along
the primary MDS axis. This analysis shows that the parental species and the hybrids have consistent protein expression levels. b Normalized
counts of peptides detected by mass spectrometry for homologous proteins in the hybrids, compared to parental values, with y = x line plotted
for reference. Although most of the hybrid data points lie outside the parental means (12 of 14, 1-sample proportions test, p = 0.00011), suggesting
either under- or overdominance, common in hybrids, the overall the slope and the intercept of the best fit are not different from y = x (p = 0.36). Both
analyses show that the hybrid proteomes are on average intermediate relative to those of P. elegans and P. flavoviridis, suggesting strong genetic
effects on both their compositions and component levels
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production as a function of overall metabolism [114],
more abundant components must necessarily carry a
higher biosynthetic cost to the snake. Therefore, snakes
should optimize the abundance of venom constituents
to maximize immobilizing power, while minimizing
cost. Both venom gene expression levels and gene
product sequences should be under strong selective
pressure. This seems to be the case generally in Proto-
bothrops, at least for sequences above dN/dS = 1 (Fig. 6),
which all showed some evidence of positive selection,
in our study and in earlier studies of accelerated evolu-
tion, which covered C-type lectins, serine proteases and
PLA2s [28, 30, 37, 115], and also in our re-analysis
(Table S3). This suggests that the higher rates of evolution
in more abundant components are due to adaptation,
rather than to relaxed selection.
Venom proteins and tissue proteins
Comparison of two closely related species that became geo-
graphically isolated several million years ago [51, 57, 58],
allowed us to examine the interplay between venom com-
position and evolutionary rate of venom proteins. Their
venoms show much greater sequence divergence than
venom gland cellular (tissue) components. Interestingly,
while secreted venom components have evolved much
faster than the cellular (non-secreted) portion of the
venom gland transcriptome, more abundant venom pro-
teins evolved most rapidly (Fig. 6). This pattern contrasted
with the cellular portion of the venom gland transcrip-
tome, where there was a negative relationship between
protein abundance and evolutionary rate, similar to that
found in most organisms [116, 117]. Together with data
including other Protobothrops species, which show evi-
dence for positive selection on the most abundant venom
components (Table S3), this strongly argues against the
suggestion that snakes inject so much venom into their
prey that the resulting ‘overkill’ greatly relaxes selection on
venom components [45, 118].
Extending the present analysis to other datasets
Patterns observed in the two Protobothrops species ap-
pear to hold generally true for crotaline snakes, based on
data from three more species in two additional genera
(Fig. 7a). Furthermore, the recently published genome of
the king cobra (Family Elapidae) [43], shows the same
pattern (Fig. 7b). These data from four additional stud-
ies, employing a range of methodologies, also show that
more abundant snake venom proteins evolve faster. It is
also possible that other organisms that depend on pro-
teinaceous secretions for parasitism, competition, and
defense may exhibit similar patterns, though further work
will be necessary to test the generality of this conclusion,
evident in snakes.
Conclusions
The findings that venom protein concentrations can
change dramatically over relatively short periods of time,
as in the case of myotoxic PLA2s (Fig 3), and that rela-
tive concentration affects evolutionary rates of venom
constituents, helps us to understand the trade-offs
Kruskal−Wallis 






























































Fig. 6 Secreted proteins evolve rapidly, and more abundant venom toxins evolve most rapidly of all. a Violin plot of evolutionary rates of
secreted proteins (those detected by mass spectrometry in the venom) vs. the rest of the transcriptome. Secreted proteins evolve significantly
faster than the rest of the transcriptome, suggesting that they are subject to atypically strong selection within the genome. b Relationship
between abundance and nucleic acid evolutionary rate for secreted proteins. More abundant venom components, which likely represent a
greater metabolic investment for the snake, but are also more likely to contribute to the venom’s effectiveness, evolve faster. Abbreviations:
5′NT 5′-nucleotidase, CTL C-type lectin, LAO L-amino acid oxidase, MP metalloprotease, PDE phosphodiesterase, PLA phospholipase, SP serine
protease, QC glutaminyl-peptide cyclotransferase. Several unlabeled points represent proteins present in the venom at low concentrations,
but without clear pharmacological significance
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involved in venom formulation. Venoms are costly for
snakes to produce [114]. Given that venom components
can range in abundance by 3–5 orders of magnitude [42]
(Fig. 5b), their cost to the snake likely also varies greatly,
with more abundant components being more costly. Opti-
mal foraging considerations suggest that snakes should in-
vest in venom constituents in proportion to the benefit
each of them provides. Therefore, variability in efficacy of
the more abundant components will have the greatest fit-
ness consequences for the snake, and those components
should experience higher levels of selection. The higher
evolutionary rates we observe in more abundant compo-
nents are the evolutionary signature of this process. This
also suggests that changes in venom component levels, ra-
ther than protein sequence-level changes, may be the most
rapid and effective way for snakes to exploit new prey
species.
Deposition of data
Sequences of genes confirmed by mass spectrometry
were curated manually by comparison with data pub-
licly available at NCBI GenBank, and deposited in the
DNA Data Bank of Japan under accession numbers
AB984571-AB984614 for P. elegans and AB985221-
AB985266 for P. flavoviridis.
Methods
Collection of snakes and extraction of venoms
Three Protobothrops flavoviridis, three P. elegans, and
two putative hybrids were employed in this study. These
specimens were captured in Nanjo City, Itoman City,
and Yaese Town in southern Okinawa as part of a
prefectural program to remove habus from densely
inhabited areas. All animals, six males and two females,
were adults, ranging from 82 to 150 cm total length
(Table 1). Snakes were maintained at the Okinawa Pre-
fectural Institute of Health and the Environment
(OPIHE) after capture. Venoms were manually extracted
into plastic beakers, transferred to cryovials, fast frozen
on dry ice, and then stored at -30 °C until use.
Removal of venom glands
Four days after venom extraction, one animal of each
species was euthanized under pentobarbital anesthesia
(>100 mg/kg), in accordance with OIST animal care
protocols. Right and left venom glands and underlying
skeletal muscle were excised, placed individually into
2 mL cryovials, flash frozen in liquid nitrogen, and stored
at -80 °C until use.
Transcriptomics
Isolation of total mRNA from venom glands and first strand
cDNA synthesis
RNA was isolated using Qiagen RNeasy Plus Mini Kits.
One μg of total RNA was used for first strand cDNA
synthesis. ERCC ExFold RNA Spike-In Mix (Life Tech-
nologies) was included in the cDNA synthesis reaction
according to the manufacturer’s protocol. To the RNA
and spike-in mix, 2 μL of 10 μM poly T_START oligo
5′-AATTGCAGTGGTATCAACGCAGAGCGGCCGC
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTVN were
added. The 9-μL mixture was incubated at 65 °C for
3 min, and then chilled on ice. The 11-μL reaction, con-







































































Fig. 7 Data sets from two snake families show that more abundant venom proteins evolve more rapidly. Both panels show evolutionary rates,
averaged by toxin class, as a function of abundance, using data from five crotaline species in three Old and New World genera (a), and the king
cobra genome (re-analyzed from Fig. 5 in Vonk et al. [43]) (b). These results mirror the pairwise differences between P. elegans and P. flavoviridis
shown in Fig. 6. In both cases, average evolutionary rates for the most abundant toxin classes tend to lie above dN/dS > 1, suggesting positive
selection. Analyses for the two families are presented separately, because they vary greatly in toxin class composition and relative abundance of
venom constituents. Significance of the associations was computed using Spearman’s rank correlation. Abbreviations: 3FTX: 3-finger toxins, APA:
Aminopeptidase A, BPP: bradykinin-potentiating peptide, GBL: galactose-binding lectin, CRISP: cysteine-rich secretory proteins, DPP: dipeptidylpeptidase IV,
HYAL: hyaluronidase, NGF: nerve growth factor, VEGF: vascular endothelial growth factor (see additional abbreviations in Fig. 6)
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1 μL of 10 mM dNTP (Promega), 2 μL of 0.1 M DTT (Invi-
trogen), 2 μL of 12 μM template-switching RNA oligo (5′-
AAGCAGUGGUAUCAACGCAGAGUACAUGGG), 1 μL
RNase inhibitor (Qiagen), and 1 μL Superscript II Reverse
Transcriptase (Invitrogen) were added to each sample. Re-
actions were incubated at 42 °C for 60 min and the enzyme
was heat inactivated at 65 °C for 15 min. 80 μL MilliQ
water were added to each cDNA reaction.
Second strand cDNA synthesis
Second strand cDNA was synthesized with a limited
number of PCR cycles. The 50-μL PCR reaction con-
sisted of 1× Phusion HF buffer (Thermo Scientific),
200 μM dNTP (Promega), 0.5 μM START primer (5′-
CGCCAGGGTTTTCCCAGTCACGACAATTGCAGT
GGTATCAACGCAGA), 0.5 μM TS_long primer (5′-
CTTGTAGGTTAAGTGGAGAGCTAACAATTTCAC
ACAGGAAAGCAGTGGTATCAACGC), 0.5 μL of 2
U/μL Phusion DNA polymerase (Thermo Scientific),
and 10 μL diluted cDNA. Twelve 50-μL PCR reactions
were set up for each cDNA sample. PCR was carried
out with the following conditions: initial denaturation
at 98 °C for 30 s, with 8 cycles of denaturation at 98 °C
for 10 s, 68 °C for 6 min, followed by final extension at
72 °C for 10 min. PCR reactions were concentrated
with an Amicon Ultra-0.5 column (Millipore).
Concentrated PCR products were purified by solid
phase reversible immobilization [119] using Dynabeads
MyOne Carboxylic Acid (Invitrogen). 17 % PEG was
used for purification. 1 ng of ds-cDNA was used library
preparation and sequencing, using a Nextera XT DNA
sample kit (illumina) according to manufacturer’s direc-
tions. Ten cycles of PCR were used for library amplifica-
tion. Pooled libraries were sequenced paired-end for
250 cycles on an illumina Miseq system.
Proteomics
Reduction and alkylation of snake venoms prior to
enzymatic digestion
Crude venoms were gently vortexed for several seconds
to suspend microsomes. Reduction was accomplished by
adding 36 μL 8 M urea, 2 μL venom, 2 μL 500 mM DTT
in ultrapure water, and 10 μL 500 mM of ammonium bi-
carbonate to 200 μL PCR tubes. Tubes were incubated
at 60 °C for 45 min in an MJ PTC 200 Peltier thermocy-
cler. Then, 4 μL 500 mM sodium iodoacetate were added
to each tube and mixed gently. Tubes were incubated at
37 °C for 30 min in the dark. Afterward, an additional 2 μL
500 mM DTT were added to quench the alkylation reac-
tion. Sample desalting was done by pipetting the reaction
from the PCR tubes into 10K Nanosep centrifugal filters
(Pall Corp.) and centrifuging them at 18,407 × g for 25 min.
Samples were rehydrated with 50 μL of 50 mM ammonium
bicarbonate and were again centrifuged to further de-salt
the samples.
Tryptic hydrolyses
After the second centrifugation, 10 μL 8 M urea were
added to the membrane and the membrane surface was
wetted with the urea by rotating the tube manually.
Then 90 μL 50 mM ammonium bicarbonate were added
to the membrane and the filter was vortexed gently to
re-suspend de-salted proteins. Solutions were pipetted
from the filter and placed in clean 200 μL PCR tubes. Fi-
nally 10 μg of trypsin (Pierce 90055) dissolved in 10 μL
1 mM HCl were added to each tube. Tubes were incu-
bated 24 h at 37 °C. Then, samples were pipetted back
into their original 10K Nanosep filters and centrifuged
again at 18,407 × g for 30 min to collect the de-
proteinated filtrate which was frozen at -30 °C until ana-
lysis by mass spectrometry.
Chymotryptic hydrolyses
The procedure for chymotrypsin (Pierce 90056) was
nearly identical to that for trypsin, except that after wet-
ting the Nanosep filter with 10 μL 8 M urea, 10 μL
50 mM ammonium bicarbonate, 5 μL 200 mM CaCl2,
and 65 μL ultrapure water were added to the membrane.
All subsequent procedures were identical to those for
trypsin.
Formic acid hydrolyses
Crude venoms were gently vortexed for few seconds. Di-
gestion of proteins was done by mixing 2 μL venom,
4 μL 500 mM DTT in ultrapure water and 94 μL 2 %
formic acid (Wako 063-04192) in 200 μL PCR tubes.
Tubes were incubated for 2 h at 99 °C and then frozen
at -30 °C until analysis by mass spectrometry.
Protein sequencing
For each sample, 3 technical repeats were run for each of
the three hydrolyses; thus each sample was analyzed nine
times. For each mass spectrogram, 1 μL was injected into a
Waters nanoACQUITY UPLC Class-M with a Waters
SYNAPT G2-S High Definition Mass Spectrometer
equipped with Ion Mobility in tandem. Peptides were
trapped in a nanoACQUITY 2G-V/MTrap 5 μm Symmetry
C18 trap column at 5 μL/min, and separated in a nanoAC-
QUITY UPLC 1.7 μm BEH130 C18 75 μm × 200 mm ana-
lytical column at 300 nL/min, 35 °C, with a gradient of 3–
60 % B in 90 min. The column was equilibrated in 0.1 %
formic acid in water and the elution buffer (B) was 0.1 %
formic acid in acetonitrile. Mass spectrometer settings were
as follows: 1.8 kV spray voltage, cone voltage 30 V, ac-
quisition mode fast-DDA with ion mobility separation,
resolution 25,000 FWHM, continuum mode, mass
range 100–2,000 m/z, acquisition rate 1 Hz/function,
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quad profile manual using first mass 400, 25 % dwell
time, and a 25 % scan time ramp, second mass 600 with
25 % dwell time and third mass 800, collision energy
ramped from 25 to 45 eV, and ion mobility wave vel-
ocity 1,200 m/s. The mass spectrometer was calibrated
with Glu-fibrinopeptide B 100 fmol/uL in 50 % methanol in
water. The same solution was used as a lock mass at
1 μL/min. The top eight most intense ions from each
full MS scan were fragmented in a data-dependent
manner with CID, using an exclusion of 60 s.
Bioinformatics
Analysis of gene expression, quantitative proteomics,
and evolutionary rate correlations were performed using
the R statistical package. Scripts performing the analysis,
as well as the accompanying SQL tables are provided on
DataDryad http://dx.doi.org/10.5061/dryad.3948r.
Transcriptome assembly, quantitation and validation
8.0 and 8.5 million read pairs comprising 3.6 and 3.7
gigabases were sequenced from the P. elegans and P.
flavoviridis libraries, respectively. Sequences were
quality and adaptor trimmed using Trimmomatic, with
the SLIDINGWINDOW:4:30 MINLEN:65 parameters
and Nextera adaptor sequences [120]. Reads were then
assembled using the Trinity suite (r20131110) [121],
and then re-mapped to the assembly using the
RSEM (v1.2.13) pipeline, with bowtie2 as the mapper
[122, 123]. Ninety nine and ninety eight percent of the
reads could be mapped to the reference in this manner
for P. elegans and P. flavoviridis, respectively. Venom
transcripts in Fig 3 were manually curated individually,
and compared to published sequences.
Fragments per kilobase mapped (FPKM) output from
RSEM were used to determine the coverage cutoff for
proteomic analysis and for analysis of relative transcript
expression levels. To determine the lowest FPKM cutoff
for the transcriptomic analysis, we used the relationship
between expected and observed values for ERCC spike-
in controls. As the cutoff increased, so did the strength
of the correlation, reaching a maximum of 0.96 at FPKM
32. Assembled sequences more abundant than this cut-
off were used as reference sequences for downstream
proteomic analysis.
Well after the completion of this study, a new assembler,
VTBuilder [124], was published, specifically designed to
remedy the deficiencies of Trinity, which typically produces
large numbers of incomplete transcripts with highly diversi-
fied protein families. We validated our unfiltered assembly
and compared it against the new method by evaluating the
assembly of spike-in transcripts. We found that VTBuilder
detected only 18 and 34 of the 92 spike-in controls, for P.
elegans and P. flavoviridis, respectively, vs. 73 and 82, as-
sembled by Trinity. Furthermore, all but a few of the spike-
ins were represented by multiple sequences, as many as 22,
whereas virtually all Trinity assemblies matched a unique
spike-in control, or produced at most two matches. This
evaluation suggests that the Trinity assembly performed
well for the known sequences in our data, which spanned a
wide range of concentrations. All but one of the venom
transcripts from Fig 3 could be found in the VTBuilder as-
sembly (Pe_comp1091_c0_seq1, a low-abundance amino-
peptidase was missing). VTBuilder suggested that five pairs
of low-abundance Trinity transcripts assemblies were in-
completely assembled by the latter (three in P. elegans and
two in P. flavoviridis). In most cases, but not always,
VTBuilder transcripts had better matches to NCBI protein
data. In any case, even assuming the VTBuilder analysis
was correct in its reconstruction, no more than one of these
pairs had a homolog in the other transcriptome, so differ-
ences in assembly should not bias our estimates of evolu-
tionary rates (see below).
Evolutionary rate analysis
For purposes of evolutionary rate analysis, proteins that
had more than one high quality matching peptide from
the venom proteome were classified as venom compo-
nents; everything else was considered a tissue compo-
nent. Likely coding sequences for transcripts passing the
FPKM filter were determined using FrameDP [125]. Pu-
tative homologs were then selected among the predicted
protein sequences using reciprocal best BLAST. Predicted
protein sequence pairs were aligned using MUSCLE [126]
and codon alignments were created using PAL2NAL [127].
For each pair of codon aligned sequences, pairwise evolu-
tionary rates (the ratio of synonymous to non-synonymous
substitutions) were computed using a maximum likelihood
model implemented in PAML (parameters: runmode = -2,
cleandata = 0, model = 1, NSsites = [0]) [128]. The R script
containing the evolutionary rate analysis can be found in
the Additional file 9 and an SQL database with the raw data
has been deposited in DataDryad (see Data Accessibility
section). The combination of the R script and database is
sufficient to reproduce the entire analysis, starting after
PAML computations.
We tested the generality of relationships between toxin
abundance and evolution by combining results from the
present study with those of three recent investigations
that reported relative toxin abundances [42, 129, 130].
For each protein class, sequences greater than 150 base
pairs were codon-aligned using Geneious (v. 8.0.5), with
each alignment inspected manually for quality. Signal
peptides were detected by comparison with published
and annotated homologs and were removed. A tree for
each protein alignment was then computed using
RAXML with the GTRCAT model [131]. The free-ratio
model implemented in codeml was then used to esti-
mate evolutionary rates along all branches of each tree.
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As we were interested in only the most recent evolution-
ary events, for each protein we considered only the
branch leading up to each leaf in the tree. We then re-
moved any extreme values from the data set (dN/dS > 3),
which typically resulted from a near total lack of syn-
onymous substitutions occurring along some branches,
and averaged both the evolutionary rates and expression
levels in each class. We also computed a correlation be-
tween relative transcript abundance within a toxin class
and its evolutionary rate using values previously reported
for the king cobra genome project [43].
Detecting positive selection in Protobothrops In order
to determine whether the increased evolutionary rates
were due to relaxed or to positive selection, we added
publicly available Protobothrops sequences for genes
showing evidence of accelerated evolution (dn/ds = 1).
We found additional data for C-type lectins, PLA2s,
metalloproteases, and serine proteases. Sequence align-
ments were tested for the presence of recombination
breakpoints and partitioned using SBP, and then tested
for positive or diversifying selection using PARRIS and
MEME algorithms implemented on the DataMonkey
server [132–136].
Protein identification
Acquisition of mass spectrometric data employed a Waters
MassLynx v4.0. Chromatographic data was processed using
Waters Progenesis QI for Proteomics for mass correction
(using acquired lock mass data), alignment, normalization,
isotope grouping, peak picking, and ion drift separation,
using default values. For peptide identification, files of
fragmentation spectra (~330,000 spectra), generated
only from monoisotopic precursors, were exported in
mgf format for analysis using Mascot (version 2.4), and
Proteome Discoverer (version 1.2, using Sequest). Search
parameters for both algorithms were: a maximum of two
missed cleavages, with precursor and fragment mass toler-
ance set to 20 ppm and 0.3 Da, respectively. Carboxyami-
domethylation of cysteine was set as a fixed modification,
while methionine oxidation, asparagine and glutamine
deamidation, and N-terminal acetylation were set as vari-
able modifications for tryptic and chymotryptic digests.
Asparagine and glutamine deamidation and formylation of
peptide N-termini were set as variable modifications for
formic acid digests. Reagents used for sequencing (trypsin,
R and K; chymotrypsin, F, L, W, and Y; formic acid, D and
M) were specified in each case.
A database from our transcript data was constructed
using TransDecoder [137], http://transdecoder.github.io,
version r20131110), using a minimum length open read-
ing frame of 5 amino acids or more than 10 nucleotides,
as parameters. These relaxed settings were chosen to avoid
the loss of small natural peptides present in the venoms.
The common Repository of Adventitious Proteins – cRAP
(http://www.thegpm.org/crap/) was merged with this
constructed database for searching (Protobothrops elegans
plus cRAP = 116,501 entries; Protobothrops flavoviridis plus
cRAP = 430,984 entries; Protobothrops hybrids plus
cRAP = 237,041). Protein and peptide identifications
from Mascot and Sequest were combined, setting the
false discovery rate to 0.1 % at the peptide level. Proteins
with one hit were manually verified in all replicates
(chromatographic peak), filtering out those that did not
appear in at least 80 % of the runs.
Availability of supporting data
The R script containing the evolutionary rate analysis and
an SQL database with the raw data used in the bioinfor-
matic analysis, which contains raw mass spectrometry
data, transcript counts, and other types of data, can
be found on DataDryad: doi:10.5061/dryad.3948r The
combination of the R script and database is sufficient
to reproduce the entire analysis, starting after PAML
computations.
Additional files
Additional file 1: Supplementary Table 3.
Additional file 2: Table S1. Transcript details for the Protobothrops elegans
transcriptome. Complete transcripts are highlighted in blue; incomplete
transcripts are in yellow. Relative transcript abundance is provided in the
column “FPKM %.” These data provide the most quantitative estimates of
venom composition; however, some of the incomplete transcripts pertaining
to the same protein families (e.g., metalloproteases) may, in fact, be the same
protein, if the transcripts were completely nonoverlapping. (PDF 132 kb)
Additional file 3: Table S2. Transcript details for the Protobothrops
flavoviridis transcriptome. Details as for Additional file 2: Table S1.
(PDF 130 kb)
Additional file 4: Figure S1. Phospholipases A2 in venoms of P.
elegans, P. flavoviridis, and hybrids between the two. A. Myotoxic PLA2s.
Catalytic PLA2s have a critical Asp residue in position 48 (See panels B-D).
All of these enzymes manifest a basic residue in this position, preventing
the binding of a critical Ca2+ ion involved in catalysis. However, while
most New World crotaline myotoxins have Lys at this position, P. elegans
and some other Asian crotalines have substituted Arg. Partial transcript
comp552_c0_seq1 from P. flavoviridis is also a myotoxin, but it is a minor
venom component (Additional file 3: Table S2). Signal peptides are shown to
the left of the vertical black line. B. Acidic PLA2s. These enzymes are strongly
lipolytic and myotoxic, though much less myotoxic than the non-catalytic
myotoxins shown in panel D. C. Moderately basic PLA2s. P. flavoviridis PLA2 1 is
most similar to PL-Y, PL-X, and PLA-B. Like those in panel B, these enzymes are
strongly lipolytic and moderately myotoxic. PLA-B induces edema [12].
D. Weakly neurotoxic PLA2s. The partial transcript, P. flavoviridis comp48_c0_
seq1 is identical, as far as can be seen to PLA-N(O) [11]. (PDF 140 kb)
Additional file 5: Figure S3. Mean frequency per specimen with which
individual amino acid residues in the noncatalytic, myotoxic P. elegans
PLA2, comp43_c0_seq1, were sequenced in P. elegans and hybrid
venoms. Not only were most of the same peptides sequenced in these
venoms, but they were sequenced with the same relative frequencies.
(PDF 234 kb)
Additional file 6: Figure S5. Hybrids express most proteins found in
the two parental species. Every colored node corresponds to a transcript
and is color-coded by toxin family. The toxins are connected to black nodes
labeled with species identities, by edges whose thickness corresponds to the
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protein expression level in that species. Expression values are given as
a percentage of the total, averaged across all samples, and range from
less than 0.001 to 19 %. More detail on expression levels of individual
toxins is presented in Fig 3. Virtually all toxins are expressed in the hy-
brids, except for a few venom components, which are poorly
expressed in the parental species, and may have been missed in the
hybrids due stochasticity involved in mass spectrometric detection.
(PNG 1018 kb)
Additional file 7: Figure S2. Manual identification of CID fragment ions
from a composite spectrum using >40 MS2 spectra from the same
chromatographic peak associated with Protobothrops elegans transcript
comp103_c0_seq1. Annotation was performed using the PEAKS studio 7.0 de
novo sequencing module, followed by a search with the same database used
for Mascot searches, and manual annotation to ascertain correctness. This
process confirmed the sequence of the peptide and that Frame 1 is correct
frame for translation. (PDF 320 kb)
Additional file 8: Figure S4. Venom peptides sequenced from both
parental taxa and hybrids pertaining to transcripts for the homologous,
basic, catalytic PLA2s, P. elegans comp47_c0_seq1 and P. flavoviridis
comp41_c0_seq1. Hybrids inherited both homologs. (PDF 12 kb)
Additional file 9: Supplementary Material. (DOCX 70 kb)
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